Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Goldman Sachs Group (NY: GS )

496.51 +5.37 (+1.09%)
Streaming Delayed Price Updated: 2:51 PM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 719,633
Open 494.00
Bid (Size) 496.41 (1)
Ask (Size) 496.61 (1)
Prev. Close 491.14
Today's Range 492.48 - 498.40
52wk Range 289.36 - 517.26
Shares Outstanding 343,446,784
Dividend Yield 2.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Price Over Earnings Overview: Goldman Sachs Gr
Via Benzinga
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
BioMarin Pharmaceutical aims to achieve $4 billion in revenue by 2027, driven by Voxzogo adoption, despite emerging competition from Ascendis Pharma. Goldman Sachs maintains a "Buy" rating with a $139... 
Via Benzinga

Performance

YTD
+27.87%
+27.87%
1 Month
-2.24%
-2.24%
3 Month
+8.92%
+8.92%
6 Month
+19.57%
+19.57%
1 Year
+53.33%
+53.33%

More News

Read More
What's In Store For Nike In Q1? Analyst Highlights China Vs. North America Trends
Via Benzinga
On the Heels of Inflation, Why Experts Expect Gold Prices Will Climb to Record Highs in 2025
Via FinancialNewsMedia
Topics Economy World Trade
Exposures Interest Rates Tariff
$1000 Invested In Goldman Sachs Gr 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Spotlight on Goldman Sachs Gr: Analyzing the Surge in Options Activity
Via Benzinga
Goldman Sachs Gr's Options Frenzy: What You Need to Know
Via Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Via Benzinga
Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases
Via Benzinga
Goldman Sachs Comments On Silver After The Fed Meeting
Via Talk Markets
Topics ETFs Economy
Exposures Interest Rates
Rate Cut Shockwaves: Which Bank Stocks Will Rise or Fall?
Via MarketBeat
Topics Economy
Exposures Economy
Bitcoin: Is It Time to Buy, Sell, or Hold in Today's Changing Market?
Via The Motley Fool
Companies Run To Bond Markets After Last Week's Fed Rate Cut
Via Benzinga
Topics Bonds Economy
Exposures Debt Markets Interest Rates
Transforming Asset Management: ETFORE CEO Discusses Vision, Innovation, and Market Strategy
Via GlobePRwire
Broadcom Unveils Next-Gen Sian 2 DSP For High Performance AI Data Centers
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
This $1 Trillion Opportunity Could Make Nvidia Stock a No-Brainer Buy -- and It's Not Artificial Intelligence (AI)
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Eight Survivors
Via Talk Markets
1 Unstoppable Stock With 990% Upside, According to Cathie Wood's Ark Invest
Via The Motley Fool
Topics Electric Vehicles
Exposures Electric Vehicles
Bitcoin Still Has More Upside Potential Than Any Tech Stock, and That Includes Nvidia
Via The Motley Fool
JP Morgan Targets UK With Fresh Credit Card Offering: Report
Via Benzinga
Topics Credit Cards
Exposures Interest Rates
Chen Zhiwen: From Financial Mastermind to Global Innovator and Philanthropist
Via Get News
S&P 500, Dow Jones Hit Record Highs: Magnificent 7 Add $400 Billion After Fed's Historic Interest Rate Cut
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula
Via Benzinga
Forget Nvidia: 1 Other Data Center Stock to Buy Hand Over Fist Right Now That Virtually No One Talks About
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.